Articles with "bnabs" as a keyword



Photo from wikipedia

Broadly neutralizing HIV-1 antibody reactivity in HIV tests: implications for diagnostics.

Sign Up to like & get
recommendations!
Published in 2021 at "AIDS"

DOI: 10.1097/qad.0000000000002898

Abstract: OBJECTIVE Passive immunization with broadly neutralizing antibodies (bNAbs) is under evaluation for HIV prevention. BNAbs target gp120 or gp41, two HIV envelope antigens commonly present in diagnostic tests. Depending on bNAb type and dose administered… read more here.

Keywords: broadly neutralizing; hiv; hiv tests; bnabs ... See more keywords
Photo by charlesdeluvio from unsplash

An HIV-1 Broadly Neutralizing Antibody from a Clade C-Infected Pediatric Elite Neutralizer Potently Neutralizes the Contemporaneous and Autologous Evolving Viruses

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Virology"

DOI: 10.1128/jvi.01495-18

Abstract: More than 50% of the HIV-1 infections globally are caused by clade C viruses. To date, there is no effective vaccine to prevent HIV-1 infection. Based on the structural information of the currently available HIV-1… read more here.

Keywords: elite neutralizer; hiv; aiims p01; pediatric elite ... See more keywords
Photo from wikipedia

Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Virology"

DOI: 10.1128/jvi.01685-18

Abstract: Millions of people are still being infected with HIV decades after the first recognition of the virus. Currently, no vaccine is able to elicit bNAbs that will prevent infection by global HIV strains. Several studies… read more here.

Keywords: evolution; diversity; hiv; strain specific ... See more keywords
Photo from wikipedia

Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1

Sign Up to like & get
recommendations!
Published in 2017 at "PLoS Pathogens"

DOI: 10.1371/journal.ppat.1006235

Abstract: Broadly-neutralizing monoclonal antibodies (bNAbs) may guide vaccine development for highly variable viruses including hepatitis C virus (HCV), since they target conserved viral epitopes that could serve as vaccine antigens. However, HCV resistance to bNAbs could… read more here.

Keywords: hcv; resistance; hepatitis virus; receptor ... See more keywords
Photo by shaikhulud from unsplash

Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation

Sign Up to like & get
recommendations!
Published in 2018 at "PLoS Pathogens"

DOI: 10.1371/journal.ppat.1007024

Abstract: The extensive glycosylation of HIV-1 envelope (Env) glycoprotein leaves few glycan-free holes large enough to admit broadly neutralizing antibodies (bnAb). Consequently, most bnAbs must inevitably make some glycan contacts and avoid clashes with others. To… read more here.

Keywords: sensitivity; hybrid glycans; saturation; bnabs ... See more keywords